SEARCH

SEARCH BY CITATION

References

  • Ahn, Y., Kett, D., Gangliano-Decesare, W., Jy, W., Tiede M. & Horstman, L. (2003) Successful outcome of rituximab therapy for spontaneous refractory high titre FVIII inhibitors. Journal of Thrombosis and Haemostasis, 1(Suppl. 1) (abstract no. P1657).
  • Ancliff, P.J., Hann, I.M., Khair, K., Liesner, R. & Worsley, A. (2000) Safe, yet unsuccessful immune tolerance induction in a factor IX inhibitor patient with BeneFix® (rIX) concentrate. Haemophilia, 6, 310 (abstract no. 75).
  • Berentsen, S., Tjonnfjord, G.E., Brudevold, R., Gjertsen, B.T., Langholm, R., Lokkevik, E., Sorbo, J.H. & Ulvestad, E. (2001) Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease. British Journal of Haematology, 115, 7983.
  • Freiburghaus, C., Berntorp, E., Ekman, M., Gunnarsson, M., Kjellberg, B. & Nilsson, I.M. (1999) Tolerance induction using the Malmo treatment model 1982–1995. Haemophilia, 5, 3239.
  • Giagounidis, A.A., Anhuf, J., Schneider, P., Germing, U., Sohngen, D., Quabeck, K. & Aul, C. (2002) Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab: a pilot study. European Journal of Haematology, 69, 95100.
  • Hongeng, S., Tardtong, P., Worapongpaiboon, S., Ungkanont, A. & Jootar, S. (2002) Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab. Bone Marrow Transplantation, 29, 871872.
  • Knight, C., Paisley, S., Wight, J. & Jones, M.L. (2003) Economic modelling of different treatment strategies for haemophilia A with high-responding inhibitors. Haemophilia, 9, 521540.
  • Krause, M., Betz, C., Scharrer, I. & Krause, M. (2003) Rituximab-a challenge for the therapy of inhibitors to factor VIII. Journal of Thrombosis and Haemostasis, 1(Suppl. 1) (abstract no. P1615).
  • Leandro, M.J., Edwards, J.C., Cambridge, G., Ehrenstein, M.R. & Isenberg, D.A. (2002) An open study of B lymphocyte depletion in systemic lupus erythematosus. Arthritis and Rheumatism, 46, 26732677.
  • Martinez-Saguer, I., Klarmann, D., Knöfler, R., Escuriola-Ettingshausen, C., Funk, M., Linde, R., Aygören-Pürsün, E., Stoll, H., Klingebiel, T. & Kreuz, W. (2003) Successful immune tolerance therapy in haemophilia B patients with FIX inhibitors-a new immunesuppressive strategy. Journal of Thrombosis and Haemostasis, 1(Suppl. 1) (abstract no. P0659).
  • Wiestner, A., Cho, H.J., Asch, A.S., Michelis, M.A., Zeller, J.A., Peerschke, E.I., Weksler, B.B. & Schechter, G.P. (2002) Rituximab in the treatment of acquired factor VIII inhibitors. Blood, 100, 34263428.
  • Wight, J., Paisley, S. & Knight, C. (2003) Immune tolerance induction in patients with haemophilia A with inhibitors: a systematic review. Haemophilia, 9, 436463.